Buscador de publicacions

Publicacions

  • Howard SC, Davidson A, Luna-Fineman S, Israels T, Chantada G, Lam CG, Hunger SP, Bailey S, Ribeiro RC, Arora RS, Pedrosa F, Harif M and Metzger ML.

    A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP).

    PEDIATRIC BLOOD & CANCER . 64 Suppl 5: . Nº de cites: 46

    [doi:10.1002/pbc.26879]

  • Pascual-Pastó G, Gene-Olaciregui N, Opezzo JAW, Castillo-Ecija H, Cuadrado-Vilanova M, Paco-Mercader S, Rivero EM, Vilà-Ubach M, Restrepo-Perdomo CA, Torrebadell-Burriel M, Suñol M, Schaquevich P, Mora J, Bramuglia GF, Chantada G and Carcaboso AM.

    Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier

    JOURNAL OF CONTROLLED RELEASE . 264: 34-44. Nº de cites: 11

    [doi:10.1016/j.jconrel.2017.08.018]

  • Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.

    Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

    CANCER LETTERS . 380(1): 10-19. Nº de cites: 23

    [doi:10.1016/j.canlet.2016.06.012]

  • Winter U, Mena HA, Negrotto S, Arana E, Pascual-Pastó G, Laurent V, Suñol M, Chantada G, Carcaboso AM and Schaiquevich P.

    Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells

    PLoS One . 11(7): . Nº de cites: 21

    [doi:10.1371/journal.pone.0160094]

  • Rosé A, André N, Rozados VR, Mainetti LE, Márquez MM, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Mora J, García WG, Epelman S, Alasino C, Alonso D, Chantada G and Scharovsky OG.

    Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.

    ecancermedicalscience . 10: 672-672. Nº de cites: 10

    [doi:10.3332/ecancer.2016.672]

  • Baroni LV, Sampor C, Fandiño A, Solernou V, Demirdjian G, de Davila MT and Chantada G.

    Anterior Segment Invasion in Retinoblastoma: Is It a Risk Factor for Extraocular Relapse?

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 36(8): 509-512. Nº de cites: 14

    [doi:10.1097/MPH.0000000000000167]

  • Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, Marr BP, Brodie SE, Berra A, Chantada G and Abramson DH.

    Local and Systemic Toxicity of Intravitreal Melphalan for Vitreous Seeding in Retinoblastoma A Preclinical and Clinical Study

    Ophthalmology . 121(9): 1810-1817. Nº de cites: 97

    [doi:10.1016/j.ophtha.2014.03.028]

  • Moreno F, Sinaki B, Fandiño A, Dussel V, Orellana L and Chantada G.

    A Population-Based Study of Retinoblastoma Incidence and Survival in Argentine Children

    PEDIATRIC BLOOD & CANCER . 61(9): 1610-1615. Nº de cites: 30

    [doi:10.1002/pbc.25048]

  • Grigorovski N, Lucena E, Mattosinho C, Parareda A, Ferman S, Català-Mora J and Chantada G.

    Use of intra-arterial chemotherapy for retinoblastoma: results of a survey

    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY . 7(4): 726-730. Nº de cites: 41

    [doi:10.3980/j.issn.2222-3959.2014.04.26]

  • Chantada G, Fandiño AC, Schvartzman E, Raslawski E, Schaiquevich P and Manzitti J.

    Impact of Chemoreduction for Conservative Therapy for Retinoblastoma in Argentina

    PEDIATRIC BLOOD & CANCER . 61(5): 821-826. Nº de cites: 28

    [doi:10.1002/pbc.24857]